Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure

Journal of Cardiology

Volumn 57, Issue 3, 2011, Pages 338-344

  Funahashi, Hidehito ^a   Izawa, Hideo ^b   Hirashiki, Akihiro ^a   Cheng, Xian Wu ^a   Inden, Yasuya ^a   Nomura, Masanori ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Adrenergic receptor; Biopsy; Heart failure; MicroRNA

Indexed keywords

ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; MICRORNA; MICRORNA 10; MICRORNA 300; MICRORNA 302; MICRORNA 323; MICRORNA 422; NORADRENALIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS; CATECHOLAMINE SENSITIVITY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; GENE EXPRESSION REGULATION; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART VENTRICULOGRAPHY; HEMODYNAMICS; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NORADRENALIN BLOOD LEVEL; PHARMACOLOGIC STRESS TESTING; PROTEIN FUNCTION;

CARDIOMYOPATHY, DILATED; CATECHOLAMINES; CHRONIC DISEASE; DOBUTAMINE; FEMALE; GENE EXPRESSION REGULATION; HEART CATHETERIZATION; HEART FAILURE; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; VENTRICULAR FUNCTION;

EID: 79954994380     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.01.009     Document Type: Article

References (27)

1. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., Billingham M.E., Harrison D.C., Stinson E.B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982, 307:205-211.
2. Bristow M.R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S., Stinson E.B. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986, 59:297-309.
3. Fowler M.B., Laser J.A., Hopkins G.L., Minobe W., Bristow M.R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 1986, 74:1290-1302.
4. Scrutinio D., Napoli V., Passantino A., Ricci A., Lagioia R., Rizzon P. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur Heart J 2000, 21:927-934.
5. Vatner S.F., Yan L., Ishikawa Y., Vatner D.E., Sadoshima J. Adenylyl cyclase type 5 disruption prolongs longevity and protects the heart against stress. Circ J 2009, 73:195-200.
6. Naqvi T.Z., Goel R.K., Forrester J.S., Siegel R.J. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999, 34:1537-1544.
7. Dubois-Rande J.L., Merlet P., Roudot F., Benvenuti C., Adnot S., Hittinger L., Duval A.M., Syrota A., Castaigne A., Loisance D., Geschwind H.J. Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy. Am Heart J 1992, 124:679-685.
8. Kobayashi M., Izawa H., Cheng X.W., Asano H., Hirashiki A., Unno K., Ohshima S., Yamada T., Murase Y., Kato T.S., Obata K., Noda A., Nishizawa T., Isobe S., Nagata K., et al. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. JACC Cardiovasc Imaging 2008, 1:718-726.
9. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
10. Kaneda R., Fukuda K. MicroRNA is a new diagnostic and therapeutic target for cardiovascular disease and regenerative medicine. Circ J 2009, 73:1397-1398.
11. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L.H., et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006, 124:1169-1181.
12. Smirnova L., Grafe A., Seiler A., Schumacher S., Nitsch R., Wulczyn F.G. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 2005, 21:1469-1477.
13. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
14. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
15. Takaya T., Ono K., Kawamura T., Takanabe R., Kaichi S., Morimoto T., Wada H., Kita T., Shimatsu A., Hasegawa K. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 2009, 73:1492-1497.
16. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y., Dalton N.D., Elia L., Latronico M.V., Hoydal M., Autore C., Russo M.A., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618.
17. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
18. Somura F., Izawa H., Iwase M., Takeichi Y., Ishiki R., Nishizawa T., Noda A., Nagata K., Yamada Y., Yokota M. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 2001, 104:658-663.
19. Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., Ichihara S., Kato T., Ohshima S., Murase Y., Iino S., Obata K., Noda A., Okumura K., Yokota M. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 2005, 112:2940-2945.
20. Ungerer M., Bohm M., Elce J.S., Erdmann E., Lohse M.J. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 1993, 87:454-463.
21. Eschenhagen T., Mende U., Nose M., Schmitz W., Scholz H., Haverich A., Hirt S., Doring V., Kalmar P., Hoppner W., Seitz H.J. Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res 1992, 70:688-696.
22. Zhao Y., Ransom J.F., Li A., Vedantham V., von Drehle M., Muth A.N., Tsuchihashi T., McManus M.T., Schwartz R.J., Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129:303-317.
23. Dixon-McIver A., East P., Mein C.A., Cazier J.B., Molloy G., Chaplin T., Andrew Lister T., Young B.D., Debernardi S. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008, 3:e2141.
24. Suh M.R., Lee Y., Kim J.Y., Kim S.K., Moon S.H., Lee J.Y., Cha K.Y., Chung H.M., Yoon H.S., Moon S.Y., Kim V.N., Kim K.S. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004, 270:488-498.
25. Palmer R.D., Murray M.J., Saini H.K., van Dongen S., Abreu-Goodger C., Muralidhar B., Pett M.R., Thornton C.M., Nicholson J.C., Enright A.J., Coleman N. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 2010, 70:2911-2923.
26. Debernardi S., Skoulakis S., Molloy G., Chaplin T., Dixon-McIver A., Young B.D. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007, 21:912-916.
27. Izzotti A., Calin G.A., Arrigo P., Steele V.E., Croce C.M., De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009, 23:806-812.